Revisions of Previously Issued Financial Statements (Details) - Schedule of consolidated statements of operations - USD ($) |
6 Months Ended | 12 Months Ended |
---|---|---|
Dec. 31, 2020 |
Jun. 30, 2020 |
|
As reported [Member] | ||
Condensed Income Statements, Captions [Line Items] | ||
Change in fair value of derivative liability | ||
Net loss attributable to Akerna shareholders | $ (16,957,334) | $ (15,534,345) |
Net loss per share (in Dollars per share) | $ (1.01) | $ (1.31) |
Adjustment [Member] | ||
Condensed Income Statements, Captions [Line Items] | ||
Change in fair value of derivative liability | $ 746,852 | $ 1,962,034 |
Net loss attributable to Akerna shareholders | $ 746,852 | $ 1,962,034 |
Net loss per share (in Dollars per share) | ||
As revised [Member] | ||
Condensed Income Statements, Captions [Line Items] | ||
Change in fair value of derivative liability | $ 746,852 | $ 1,962,034 |
Net loss attributable to Akerna shareholders | $ (16,210,482) | $ (13,572,311) |
Net loss per share (in Dollars per share) | $ (1.01) | $ (1.14) |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|